Knott David M Jr
SYOSSET, NY
$189m in 84 US stocks at the end of 30 June 2026. The top 10 are 62.8% of the money. It changed about 11.7% of the portfolio this quarter.
Value
$189m
Stocks
84
Top 10 share
62.8%
Turnover
11.7%
What changed this quarter
New
Bought for the first time this quarter.
- Catalyst BancorpCLST1.9% of the fund
- Spruce BiosciencesSPRB0.6% of the fund
- DuPont de Nemours0.3% of the fund
- InsmedINSM0.2% of the fund
- LB PharmaceuticalsLBRX0.2% of the fund
- CareDxCDNA0.2% of the fund
- Q32 BioQTTB0.2% of the fund
- Enliven TherapeuticsELVN0.2% of the fund
- Boston ScientificBSX0.1% of the fund
- FS KKR CapitalFSK<0.1% of the fund
- Occidental PeteOXY-WS<0.1% of the fund
Added
Bought more of a stock they already held.
- Syndax PharmaceuticalsSNDX5.1% of the fund+4%
- Travere TherapeuticsTVTX4.4% of the fund+5%
- BridgeBio PharmaBBIO3.7% of the fund+3%
- Cogent BiosciencesCOGT2.3% of the fund+7%
- Agios PharmaceuticalsAGIO1.9% of the fund+2%
- Relmada TherapeuticsRLMD1.6% of the fund+3%
- Helus PharmaHELP1.3% of the fund+6%
- Madrigal PharmaceuticalsMDGL0.9% of the fund+50%
- ArdelyxARDX0.7% of the fund+27%
- Ultragenyx PharmaceuticalRARE0.7% of the fund+15%
- Cullinan TherapeuticsCGEM0.7% of the fund+186%
- Connect Biopharma HoldingsCNTB0.6% of the fund+15%
- Pelthos TherapeuticsPTHS0.3% of the fund+5%
- VerastemVSTM0.3% of the fund+49%
- Solid BiosciencesSLDB0.3% of the fund+19%
Cut
Sold some of their stake.
- JPMorgan ChaseJPM3.1% of the fund-7%
- TG TherapeuticsTGTX1.9% of the fund-26%
- Bristol-Myers SquibbBMY<0.1% of the fund-85%
- Occidental PetroleumOXY<0.1% of the fund-29%
Sold out
Sold their entire stake.
- Catalyst Pharmaceuticals-100%
- Arcellx-100%
- CytokineticsCYTK-100%
- Centessa Pharmaceuticals-100%
- Adma BiologicsADMA-100%
- Biohaven Pharmaceutical Holding-100%
- EvolusEOLS-100%
- LENZ TherapeuticsLENZ-100%
- DuPont de NemoursDD-100%
- Jasper TherapeuticsJSPR-100%
- Mereo Biopharma GroupMREO-100%
- FS KKR CapitalFSK-100%
Holdings
- Janus Detroit STR TRJAAA
- Share
- 2.5%
- Value
- $5m
- Shares
- 93,528
Held
- Helus PharmaHELP
- Share
- 1.3%
- Value
- $2m
- Shares
- 370,000
+6%
- Spdr Series TrustXBI
- Share
- 1.3%
- Value
- $2m
- Shares
- 15,000
Held
- Alliancebernstein Hldg L PAB
- Share
- 0.9%
- Value
- $2m
- Shares
- 48,000
Held
- Series Portfolios TRCLOZ
- Share
- 0.7%
- Value
- $1m
- Shares
- 47,807
Held
- Ishares TRIBB
- Share
- 0.6%
- Value
- $1m
- Shares
- 5,500
Held
- Canadian Natural ResourcesCNQ
- Share
- 0.4%
- Value
- $663,600
- Shares
- 16,800
Held
- DuPont de Nemours
- Share
- 0.3%
- Value
- $510,956
- Shares
- 3,767
New
- Ishares TRIWP
- Share
- <0.1%
- Value
- $101,755
- Shares
- 695
Held
- Occidental PeteOXY-WS
- Share
- <0.1%
- Value
- $4,268
- Shares
- 194
New
| Company | Share of fund | Value | Shares | Change |
|---|---|---|---|---|
| AlphabetGOOG | 17.1% | $32m | 91,420 | Held |
| Apollo Global ManagementAPO | 14.1% | $27m | 225,000 | Held |
| Syndax PharmaceuticalsSNDX | 5.1% | $10m | 437,245 | +4% |
| Xeris Biopharma HoldingsXERS | 4.4% | $8m | 1,060,000 | Held |
| Travere TherapeuticsTVTX | 4.4% | $8m | 147,282 | +5% |
| Protagonist TherapeuticsPTGX | 4.1% | $8m | 63,000 | Held |
| BridgeBio PharmaBBIO | 3.7% | $7m | 92,850 | +3% |
| Iovance BiotherapeuticsIOVA | 3.5% | $7m | 1,600,000 | Held |
| Alkermes plc.ALKS | 3.4% | $6m | 121,759 | Held |
| JPMorgan ChaseJPM | 3.1% | $6m | 18,098 | -7% |
| Janus Detroit STR TRJAAA | 2.5% | $5m | 93,528 | Held |
| LPL Financial HoldingsLPLA | 2.5% | $5m | 16,500 | Held |
| Cogent BiosciencesCOGT | 2.3% | $4m | 111,081 | +7% |
| TG TherapeuticsTGTX | 1.9% | $4m | 66,839 | -26% |
| Catalyst BancorpCLST | 1.9% | $4m | 114,000 | New |
| Agios PharmaceuticalsAGIO | 1.9% | $4m | 95,058 | +2% |
| Viridian TherapeuticsVRDN | 1.8% | $3m | 181,000 | Held |
| Relmada TherapeuticsRLMD | 1.6% | $3m | 451,000 | +3% |
| Arcus BiosciencesRCUS | 1.3% | $3m | 81,241 | Held |
| Helus PharmaHELP | 1.3% | $2m | 370,000 | +6% |
| Spdr Series TrustXBI | 1.3% | $2m | 15,000 | Held |
| RezoluteRZLT | 1.0% | $2m | 370,000 | Held |
| Alliancebernstein Hldg L PAB | 0.9% | $2m | 48,000 | Held |
| Madrigal PharmaceuticalsMDGL | 0.9% | $2m | 3,000 | +50% |
| AtriCureATRC | 0.8% | $1m | 51,400 | Held |
| DocGoDCGO | 0.7% | $1m | 2,670,850 | Held |
| ArdelyxARDX | 0.7% | $1m | 263,168 | +27% |
| Ultragenyx PharmaceuticalRARE | 0.7% | $1m | 38,069 | +15% |
| Series Portfolios TRCLOZ | 0.7% | $1m | 47,807 | Held |
| Cullinan TherapeuticsCGEM | 0.7% | $1m | 69,182 | +186% |
| Johnson & JohnsonJNJ | 0.7% | $1m | 4,922 | Held |
| Vera TherapeuticsVERA | 0.6% | $1m | 26,000 | Held |
| Orchestra BioMed HoldingsOBIO | 0.6% | $1m | 253,651 | Held |
| Spruce BiosciencesSPRB | 0.6% | $1m | 20,000 | New |
| Connect Biopharma HoldingsCNTB | 0.6% | $1m | 444,862 | +15% |
| Ishares TRIBB | 0.6% | $1m | 5,500 | Held |
| BiogenBIIB | 0.5% | $864,240 | 4,000 | Held |
| PfizerPFE | 0.4% | $778,675 | 32,337 | Held |
| AppleAAPL | 0.4% | $721,664 | 2,494 | Held |
| Canadian Natural ResourcesCNQ | 0.4% | $663,600 | 16,800 | Held |
| Pelthos TherapeuticsPTHS | 0.3% | $623,783 | 22,073 | +5% |
| International Business MachinesIBM | 0.3% | $602,352 | 2,142 | Held |
| MicrosoftMSFT | 0.3% | $596,832 | 1,600 | Held |
| VerastemVSTM | 0.3% | $592,100 | 155,000 | +49% |
| Kura OncologyKURA | 0.3% | $578,854 | 52,767 | Held |
| Solid BiosciencesSLDB | 0.3% | $561,518 | 56,208 | +19% |
| DuPont de Nemours | 0.3% | $510,956 | 3,767 | New |
| InsmedINSM | 0.2% | $453,455 | 4,253 | New |
| LB PharmaceuticalsLBRX | 0.2% | $420,779 | 12,965 | New |
| CareDxCDNA | 0.2% | $388,455 | 13,630 | New |
| Q32 BioQTTB | 0.2% | $387,449 | 30,412 | New |
| Enliven TherapeuticsELVN | 0.2% | $313,787 | 6,183 | New |
| Ryman Hospitality PropertiesRHP | 0.2% | $308,520 | 2,400 | Held |
| BroadcomAVGO | 0.1% | $268,202 | 710 | Held |
| Kimberly-ClarkKMB | 0.1% | $263,448 | 2,400 | Held |
| NvidiaNVDA | 0.1% | $256,115 | 1,280 | Held |
| Boston ScientificBSX | 0.1% | $256,080 | 6,000 | New |
| Wave Life SciencesWVE | 0.1% | $232,400 | 40,000 | Held |
| Rain Enhancement Technologies HoldcoRAIN | 0.1% | $210,490 | 101,686 | Held |
| Mondelez InternationalMDLZ | <0.1% | $173,520 | 3,000 | Held |
| Quanta ServicesPWR | <0.1% | $126,727 | 176 | Held |
| Bristol-Myers SquibbBMY | <0.1% | $115,240 | 2,000 | -85% |
| Eastern BanksharesEBC | <0.1% | $111,200 | 5,000 | Held |
| AlphabetGOOGL | <0.1% | $107,211 | 300 | Held |
| Legacy HousingLEGH | <0.1% | $105,080 | 4,000 | Held |
| CortevaCTVA | <0.1% | $102,136 | 1,206 | Held |
| Ishares TRIWP | <0.1% | $101,755 | 695 | Held |
| United RentalsURI | <0.1% | $88,365 | 78 | Held |
| InvivydIVVD | <0.1% | $87,240 | 100,000 | Held |
| Amazon.comAMZN | <0.1% | $71,502 | 300 | Held |
| DanaherDHR | <0.1% | $34,286 | 180 | Held |
| DOWDOW | <0.1% | $32,996 | 1,206 | Held |
| FS KKR CapitalFSK | <0.1% | $30,187 | 2,875 | New |
| Brightstar LotteryBRSL | <0.1% | $26,800 | 2,500 | Held |
| BlackstoneBX | <0.1% | $24,711 | 210 | Held |
| UnitedHealth GroupUNH | <0.1% | $23,691 | 57 | Held |
| Occidental PetroleumOXY | <0.1% | $22,779 | 469 | -29% |
| Thermo Fisher ScientificTMO | <0.1% | $22,561 | 45 | Held |
| SalesforceCRM | <0.1% | $12,063 | 77 | Held |
| Starwood Property TrustSTWD | <0.1% | $6,552 | 400 | Held |
| Kyndryl HoldingsKD | <0.1% | $4,841 | 428 | Held |
| Occidental PeteOXY-WS | <0.1% | $4,268 | 194 | New |
| GE HealthCare TechnologiesGEHC | <0.1% | $3,200 | 50 | Held |
| Westinghouse Air Brake TechnologiesWAB | <0.1% | $1,618 | 6 | Held |
Over time and by industry
Value over time
Jun '25
Dec '25
Jun '26
Value is down 14.2% since 30 June 2025.
Where the money is
Health care52.6%
Financial services21.6%
Media & telecom17.1%
Technology1.3%
Energy0.4%
Everyday goods0.2%
Industrials0.2%
Real estate0.2%
Materials0.1%
Retail & consumer0.1%
Other6.2%
From the fund's 13F filings. They list US stocks and options only, 45 days after each quarter, and leave out cash, bonds, shorts and foreign shares.